- Home
- FRME vs RXRX Comparison
FRME vs RXRX Comparison
Compare FRME & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRME | RXRX |
|---|---|---|
| Founded | 1893 | 2013 |
| Country | United States | United States |
| Employees | 2086 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FRME | RXRX |
|---|---|---|
| Price | $39.45 | $3.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $48.33 | $7.50 |
| AVG Volume (30 Days) | 301.8K | ★ 10.2M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $27.67 | $12.11 |
| Revenue Next Year | $5.91 | $82.52 |
| P/E Ratio | $10.90 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $34.66 | $2.80 |
| 52 Week High | $43.22 | $7.18 |
Technical Indicators
Market Signals| Indicator | FRME | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 52.19 |
| Support Level | $38.77 | $2.89 |
| Resistance Level | $41.81 | $3.99 |
| Average True Range (ATR) | 0.73 | 0.17 |
| MACD | -0.13 | 0.03 |
| Stochastic Oscillator | 15.17 | 56.53 |
Price Performance
Historical ComparisonAbout FRME First Merchants Corporation
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment, which is community banking.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.